Introduction
Abuse of the club drug 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) can result in life threatening hyperthermia with maximum body temperature correlating with mortality (Gowing et al., 2002) . Along with hyperthermia, persons with MDMA-induced toxicity can develop rhabdomyolysis, muscle rigidity (Dar and McBrien, 1996) , renal failure (Fahal et al., 1992) and hyperkalemia (Ravina et al., 2004) . Despite its popularity and prevalent usage, we have only recently begun to understand the thermogenic mechanisms of MDMA and how they contribute to human toxicities.
Hyperthermia induced by MDMA involves a complex interaction between the hypothalamic-pituitary-thyroid axis and the sympathetic nervous system (Sprague et al., 2003) . Removal of either the pituitary or thyroid gland prevents MDMA-induced hyperthermia and paradoxically generates a hypothermic response (Sprague et al., 2003) . Similarly, rats treated with MDMA have been shown to have elevated circulating T4 levels (Sprague et al., 2003) , a finding that has been noted in human abusers of amphetamines (Morley and Shafer, 1982) . MDMA-mediated thermogenesis is also dependent on activation of the sympathetic nervous system because antagonists of suggests that the action of α 1 ARs in skeletal muscle thermogenesis may also involve more than changes in regional blood flow (Zhao et al., 1997) . Along with elevations in core temperature, rats treated with MDMA have significantly elevated temperatures in their skeletal muscle, which can be blocked by β 3 AR antagonists (Sprague et al., 2003) . The thermogenic inhibitory properties of β 3 AR blockade in the skeletal muscle of MDMA treated rats suggests a role for uncoupling proteins and non-shivering thermogenesis in MDMA-mediated hyperthermia.
Patients ingesting the herbicidal agents dinitrophenol (2,4-Dinitrophenol) and pentachlorophenol have similar clinical presentations to MDMA toxicity. Symptoms that have been reported include rhabdomyolysis, muscle rigidity, hyperkalemia, metabolic acidosis, tachycardia, diaphoresis and most commonly hyperpyrexia.
( Leftwich et al., 1982) The toxic molecular mechanisms of 2,4-dinitrophenol and pentachlorophenol have been well established; these protonophoric agents uncouple mitochondrial electron transport chain activity from ATP synthesis by inducing a leak of protons across the mitochondrial inner membrane into the mitochondrial matrix (Skulachev, 1998) .
The primary site of non-shivering thermogenesis in rats is brown adipose tissue, not muscle, due to the activation of uncoupling protein 1 (UCP-1) (Nicholls and Locke, 1984) . Although adult humans have little brown fat or UCP-1, UCP-3, a protein with significant homology to UCP-1, is abundantly expressed in human and rodent skeletal muscle. (Boss et al., 1997) Like UCP-1, UCP-3 is regulated through the activation of peroxisome proliferator receptor elements (PPRE) and thyroid hormones. (Gong et al., 1997; Teruel et al., 2000) Recently, UCP-3 deficient mice JPET #79236 6 treated with MDMA were shown to have a blunted hyperthermic response and were resistant to its lethal effects (Mills et al., 2003) . These findings strongly suggest that MDMA mediated thermogenesis involves UCP-3 and the uncoupling of oxidative phosphorylation.
Although a link has been established between UCP-3 and MDMA-mediated hyperthermia, it is not clear whether MDMA is a direct uncoupler of mitochondrial respiration like 2,4-dinitrophenol, or whether its mechanisms are indirect. We recently demonstrated that the effects of MDMA on respiratory uncoupling in liver mitochondria are modest and only observed at concentrations far exceeding (>1000 times) that of serum levels in humans users (Rusyniak et al., 2004) . One possible explanation for this relative lack of effect may be that uncoupling proteins, while widely present in a variety of tissues are not highly expressed in hepatocytes (Larrouy et al., 1997) . The present study was designed to biochemically define the effects of MDMA on mitochondrial uncoupling in relation to MDMA-mediated hyperthermia, rhabdomyolysis and ATP levels in skeletal muscle.
Methods

Materials
(±) MDMA was generously provided by the National Institute of Drug Abuse (NIDA) and was dissolved in water prior to usage. All other chemicals used were purchased from the Sigma Chemical Company (St. Louis, MO).
Animals
Both naïve and jugular vein cannulated (JVC), male Sprague Dawley rats (175-300 g) were purchased from Harlan (Indianapolis, Indiana). All animals were housed in groups of two or three and given ad libitum access to food and drinking water. Housing conditions were maintained at a constant temperature of 22-24°C and a 12:12-h light/dark cycle. The JVC animals received complete cannula heparin 
MDMA and rhabdomyolysis in rats
Jugular vein cannulated rats were divided into the following treatment groups: control (vehicle, n=12) or MDMA (40 mg/kg, sc; n=10). Thirty minutes before and 4 hours after MDMA administration, 500 µ L of blood was collected per animal through the JVC cannula and replaced with an equal volume of saline. Each animal served as its own control for changes in baseline creatine kinase. Collected blood was allowed to clot for 30 minutes at room temperature and centrifuged at 10,000 X g for JPET #79236
8 10 minutes at 4°C. After serum was collected the samples were immediately frozen at -80 º°C. Creatine kinase levels were determined by using the Vitros analyzer 
In vivo measurement of ATP and phosphocreatine in MDMA treated rats
Rats were injected with urethane (1.75-2g/kg sq) and once anesthetized a 24 gauge angiocatheter was sutured into the peritoneal cavity and connected to a 60-inch long extension tube (total volume of 0.47 ml) allowing injections to be administered from outside of the NMR spectrometer. Fiber optic temperature probes (FISO Commander, UMI version 1.9, Quebec, Canada) were placed 1-2 cm into the rectum and into the lateral hind leg of the limb without the NMR coil.
The animal was positioned on top of a water recirculating heating pad and gently secured inside a specially designed NMR probe constructed out of a 66-cm long section of 69-mm diameter acrylic tubing. A 0.9-cm diameter surface coil tunable to 106 MHz for 23 Na and 161.8 MHz for 31 P was placed directly over the lateral hind leg with a small glass bulb containing 400 mM phenylphosphonic acid (PPA) placed on top of the surface coil as an external reference for 31 P spectra.
Calculations of all phosphate peak areas were done with respect to PPA signal area.
All NMR experiments were performed on a 9.4 T, 89 mm vertical bore magnet interfaced to a Varian INOVA console (Varian, Inc. Palo Alto, CA). The magnet was shimmed using the 23 Na signal to ~60-80 Hz line width. Then, the surface coil was tuned to 161.8 MHz and 31 P spectra were collected using a 10 µs excitation pulse followed by acquisition of 3072 data points over a spectral width of 15 kHz. Twohundred-fifty-six free-induction-decays (FIDs) were averaged over 4 min 44 sec for each spectrum. All NMR data were transferred to a personal computer and processed with NMR Utility Transform Software (NUTS, Acorn NMR, Fremont, CA, USA) for Windows 95/NT. 
Effects of MDMA on mitochondrial oxidative phosphorylation
Mitochondria were isolated from the hind legs of adult male Sprague-Dawley rats using a method of protease digestion and differential centrifugation based on a previously reported protocol (Kerner et al., 2001) . Final mitochondrial protein concentrations were determined by Bradford Assay using BSA as a standard.
Oxygen consumption in isolated mitochondria was monitored using a Clark oxygen electrode (Hansatech, Norfolk England) kept at a constant 25 °C with a computerized oxygraph. Reactions were performed in a Reaction Medium containing 125 mM potassium chloride, 4 mM potassium phosphate, 10 mM MOPS, 2 mM magnesium chloride at a pH of 7.4. Experiments were conducted as described in Figure 1 with the concentrations of MDMA being 0.1, 0.5, 1.0 and 5.0 mM for individual experiments. Rates of respiration as well as respiratory control index (RCI) and ADP/oxygen ratio's were calculated according to standard procedures (Estabrook, 1967) .
To determine the effect of MDMA on mitochondrial oxidative phosphorylation ex vivo, male Sprague-Dawley rats were allocated to receive either MDMA (40mg/kg in 1mL H 2 O, sq) or an equal volume of H 2 O. Animals were euthanized by decapitation 1 hour after MDMA treatment with skeletal muscle mitochondrial isolation performed as described above. The experimental design is shown in Figure   2 .
MDMA biotransformation and toxicity in muscle cell culture
To determine the effects of MDMA metabolites on the toxicity of skeletal Primary hepatocytes were isolated from male Sprague Dawley rats using collagenase perfusion (Seglen, 1993) HAM'S Complete Media plus 5% FBS (see above for contents) and incubated at 37°C, 5%CO2, 95% 02 with gentle rocking at 30 and 60 minutes post plating. Cell viability was determined via trypan blue exclusion and was always greater than 80%.
The media was changed after 4 hours and the cells were then incubated overnight and used the next day.
Creatine kinase activity of the cells was determined using a modification of a previously described microtiter plate reader technique (Maglara et al., 2003) . The myotubes were washed twice in 1mL D-PBS for 30 minutes each at 37°C, then harvested in 1mL D-PBS with a rubber policeman and sonicated. The creatine kinase assay was carried out by mixing 50µl of the sonicated cell sample and 200µl
of creatine kinase assay reagent (50mmol/L triethanolamine buffer pH 7.2, Creatine kinase activity was determined as described above. To assure the viability of the primary hepatocytes in the experimental conditions preliminary experiments were done incubating primary hepatocytes in DPBS for 3 hours and measuring lactate dehydrogenase (LDH) release and trypan blue exclusion. This data showed no evidence of increased LDH release and greater than 75% cell viability (data not shown).
Western blotting 100 micrograms of L6 myotube protein were loaded into each lane of a BioRad minigel system. As a negative control, muscle mitochondria (75 micrograms mitochondrial protein) from UCP3 -/-mice were used. As a positive control, recombinant murine UCP3 (prepared in one of our laboratories, MEH) was used. creatine kinase concentrations, rates of respiration and change in temperatures for animals treated with MDMA were compared using t-test. Changes in phosphocreatine and β-ATP and temperatures in the NMR experiments were compared using repeated analysis of variance (ANOVA) with each time point compared back to baseline using a Dunnet's multiple comparison procedure.
Statistical significance was set a priori at a value of p<0.05.
Results
MDMA and rhabdomyolysis in rats
Rats treated with MDMA (40 mg/kg, sq) developed stereotypical serotonin behavioral syndrome with significant increases in temperatures at 2 hours from baseline in the MDMA treated animals (37.2 ± 0.2 °C to 39.1 ± 0.3 °C; p = 0.0001).
Serum creatine kinase levels, a marker of rhabdomyolysis, were significantly Decreases in β-ATP signal area were accompanied by corresponding increases in inorganic phosphate (88% increase) and decreases in intracellular pH. (Figure 5 )
The phosphocreatine signal also showed a small (8%) nonsignificant decrease after MDMA injection. (Figure 5 ). An additional 3 rats were examined to determine the effects of the experimental conditions on core and skeletal muscle temperatures and phosphocreatine and β-ATP signals using saline as a control. There were no significant changes in skeletal muscle and core body temperatures or phosphocreatine and ATP signal intensity over time (Figures 3, 4 and 5). 
Effects of MDMA on mitochondrial oxidative phosphorylation in isolated mitochondria
UCP3 protein expression in L6 myotubes
The results shown in figure 7 demonstrate that UCP-3 protein is expressed in L6 myotubes 5 days after the induction of differentiation.
Discussion
Agents which uncouple oxidative phosphorylation can result in severe and life threatening hyperthermia. Recent studies have established a link between MDMAinduced hyperthermia, UCP-3 and β 3 ARs (Mills et al., 2003; Sprague et al., 2003) .
Although a role for mitochondrial uncoupling has been suggested to play a role in the hyperthermia induced by MDMA to date there have been no studies which have defined biochemically the action of MDMA on mitochondrial uncoupling. In a previous study, we demonstrated that MDMA has very little effect on respiratory coupling in isolated liver mitochondria (Rusyniak et al., 2004) . Conclusions based upon these findings are limited however, because UCPs are not abundant in hepatocytes (Larrouy et al., 1997) . Thus, here we focused on the effects of skeletal muscle mitochondria, where UCP-3 is predominantly expressed (Boss et al., 1997) .
Myocytes rely on oxidative phosphorylation and the hydrolysis of high-energy phosphate bonds from phosphocreatine in the formation of ATP. Alterations in the concentration of either phosphocreatine or ATP can result in energy requirements exceeding ATP production ultimately leading to muscle cell breakdown and rhabdomyolysis (Curry et al., 1989) . Rhabdomyolysis is one of the most commonly reported complications in human users of MDMA (Dar and McBrien, 1996) . Here, we show similar effects in rodents treated with MDMA. Four hours after MDMA treatment, serum creatine kinase levels were nearly 3-fold higher in the MDMA treated animals. Other amphetamines, including methamphetamine and amphetamine also cause rhabdomyolysis in human users (Kendrick et al., 1977; Richards et al., 1999) . Consistent with ATP depletion, muscle rigor and hyperkalemia are also reported as part of the panoply of symptoms mediated by MDMA toxicity (Dar and McBrien, 1996; Ravina et al., 2004) . In our experiments we measured total creatine kinase activity and did not differentiate the various isoforms.
It is possible that other creatine kinase isoforms, including MB, may have also contributed to the total creatine kinase increases we saw. A recent study showing structural damage to the skeletal muscle of MDMA treated mice, however supports that the creatine kinases in our study are secondary to skeletal muscle release (Duarte et al., 2005) .
Previous investigators have shown rapid and transient decreases in ATP in
the mouse striatum after multiple doses of methamphetamine a phenylethylamine similar to MDMA (Chan et al., 1994) . Methamphetamine in a cumulative dose of 40 mg/kg over 6 hours, resulted in a 20% reduction in ATP concentrations (Chan et al., 1994) . Along with decreases in ATP, methamphetamine administration increases concentrations of extracellular lactate (Stephans et al., 1998) , glucose and brain glycogen (Darvesh et al., 2002) suggesting an acute and rapid derangement in mitochondrial energy production. Similar effects on glycogen content have also been noted in studies with d-amphetamine and other amphetamine analogs (Nahorski and Rogers, 1973; Nowak, 1988) . Although these prior studies implicate an effect of stimulants on energy production in the brain, recent work has also shown a role for skeletal muscle in MDMA mediated hyperthermia (Mills et al., 2003) . Using 31 P NMR, a well recognized non-invasive tool for measurement of bioenergetic processes, we observed a 15% reduction in the skeletal muscle ATP signals 3 hours after a single 40 mg/kg MDMA dose. These decreases were seen in conjunction with an 88% increase in inorganic phosphate and a reduction in intracellular pH.
Although to a lesser extent (8%), the signal for phosphocreatine also showed a similar trend toward reduction after MDMA treatment. These data when viewed in light of the corresponding skeletal muscle hyperthermia strongly suggests impairment of mitochondrial oxidative phosphorylation. As these animals were anesthetized and immobile, the effects of MDMA seen in this study are more consistent with a reduction in energy supply instead of excess consumption. In support of this, a study by Gordon et al showed large increases in the metabolic rates of MDMA treated (30 mg/kg) rats (Gordon et al., 1991) and a similar study a rapid increase in oxygen consumption paralleling the rise in core body temperature with methamphetamine (1 mg/kg) (Makisumi et al., 1998). Likewise our findings are similar to those obtained from rats treated with the classic uncoupler 2,4-dinitrophenol (Byrne et al., 1985; Jucker et al., 2000) . We believe these prior findings along with our NMR data support a role for uncoupling of oxidative phosphorylation from MDMA. There are however other possible explanations for our results, one being a decreased blood flow to the lower extremities. Although we did not measure blood flow, the skeletal muscle hyperthermia seen suggests well perfused tissues.
Other researchers have shown increases in the mean arterial pressure in conscious animals suggesting increased perfusion. (Badon et al., 2002) The animals in the present study were anesthetized and this may have affected perfusion. Urethane can lower blood pressure, but depends on the route of administration with these effects not seen with subcutaneous urethane as administered in our study As hypoxia and hypoperfusion can both decrease ATP and phosphocreatine concentrations these possibilities should be explored in future experiments.
One of the most perplexing findings in the present study is the relationship between the ATP signal area and the relative lack of decrease seen in the Despite the findings above, we found little evidence of a direct effect of MDMA on the bioenergetics of isolated skeletal mitochondria. Although a small non significant increase was noted for complex 1 and 2 substrates in state 4 respiration with a corresponding decrease in the RCI values, the magnitude of this effect was small when compared to 2,4-dinitrophenol. Only at MDMA concentrations corresponding to greater than 1000 times those found in human cases did we note any significant effects. These effects were noted only for the RCI and not state 4 respiration which is the respiratory state most effected by uncoupling. The mitochondria of MDMA-treated animals likewise showed similar respiratory parameters to controls with the minimal amount of uncoupling seen in the in vitro mitochondrial isolations no longer evident in the treated animals. These differences may be due to the lower concentrations of MDMA that the skeletal muscle mitochondrial were likely exposed to in the treated animals compared to 5 mM in the in vitro studies. In isolated mitochondria work however, results must be interpreted with some caution as the experimental conditions may result in required ions and or co-factors being lost or altered during the preparation. The main reason for our testing MDMA in the isolated mitochondrial preparations was to elicit whether it had any direct uncoupling activity. As amphetamines can cross membranes in both their neutral and protonated species, by cycling across the membrane they could act as a classic uncoupler. In high concentrations this has been demonstrated with chlorphentermine, another phenylethylamine. (Zychlinski and Montgomery, 1985) Given that we saw no significant evidence of uncoupling in our preparations at concentrations as high as 5 mM is indicative that this classic uncoupling is not likely responsible for the effects we saw in the in-vivo studies. If MDMA works through β AR as we hypothesize we would not expect to see evidence of this in the isolated mitochondria which lack a cell membrane and hence β AR. Together the data from these experiments suggest that direct effects of MDMA on mitochondria are minimal and are not likely responsible for the physiological responses seen in vivo.
MDMA and its metabolites, including methylenedioxyamphetamine, produce hyperthermia (O'Callaghan and Miller, 1994) . To determine a possible direct effect of MDMA or its metabolites on the skeletal muscle, we employed a co-culture assay with L6 myotubes and primary hepatocytes. In this study, we demonstrated the presence of UCP-3 by western blot in L6 myotubes ( Figure 6 ). Previous studies have only demonstrated the presence of UCP-3 mRNA in L6-myotubes. (Nagase et al., 1999) The L6 cell line has also been used as a model of myotoxity with similar findings in vitro to known in-vivo effects of toxins (Kato et al., 1992) . As amphetamines (Green et al., 1986) and MDMA (Lim and Foltz, 1988) are extensively metabolized by the liver, we employed a model of co-culture with primary hepatocytes and L6 myotubes. In our experiments we saw no evidence of toxicity from either MDMA alone or in co-culture despite the use of concentrations as high as 5 mM. This finding is in contrast to the results we obtained in rats treated with MDMA, in which serum creatine kinase increased nearly 3-fold and would suggest a more integrative mechanism of toxicity not replicated in our in-vitro studies. 2,4-dinitrophenol however produced marked toxicity as has been previously reported (Maglara et al., 2003) . Although 2,4-dinitrophenol has no known interactions with uncoupling proteins, it uncouples oxidative phosphorylation with adverse effects in humans which parallel those of MDMA. It is important to mention however that since we did not measure oxidative phosphorylation directly in these cells it is possible that there was some mild uncoupling that was insufficient enough to affect creatine kinase release in our in vitro model. L6 cells also have significant differences with mature skeletal myofibers including slower differentiation, absence of Insulin growth factors, and a more limited number of myogenic cell markers. (Neville et al., 1997) We believe however, that the demonstration of UCP-3 in this cell model, and previous work showing that UCP3 in L6 cells is regulated by thyroid hormones and β AR agonists (Nagase et al., 1999; Nagase et al., 2001 ) similar to mature skeletal muscle makes this line a suitable model for in-vitro work with MDMA.
The dependence on UCP-3 for skeletal muscle hyperthermia induced by MDMA (Mills et al., 2003) and the lack of a direct effect observed in the current study suggests that MDMA's effects on uncoupling proteins are indirect. Because skeletal muscle hyperthermia is attenuated by antagonists of β 3 adrenergic receptors (Sprague et al., 2003) , the β 3 AR agonist, norepinephrine, may mediate the mitochondrial effects seen with MDMA. Similar to UCP-1, UCP-3 is regulated by β 3 ARs through norepinephrine, and thyroid hormones (Gong et al., 1997) . Thyroid hormones work in concert with the sympathetic nervous system, amplifying intracellular levels of cyclic AMP from β AR stimulation (de Jesus et al., 2001 ).
Together, the actions of the thyroid and sympathetic nervous system result in a synergistic, acute activation of uncoupling proteins, with corresponding increases in respiration up to 450% in brown adipose tissue and 35% in skeletal muscle have been shown to have higher levels of plasma norepinephrine and dopamine compared with non-users (Stuerenburg et al., 2002) . Similarly, rats treated with the same 40 mg/k dose of MDMA used in this study, also demonstrate a 35-fold increase in plasma norepinephrine levels (Sprague et al., in press) . 
